arrow
S

Stefania Spila Alegiani

Istituto Superiore di Sanità
H指数:25
被引数:1,978

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network

利妥昔单抗用于血液系统恶性肿瘤的十年趋势:一项基于意大利VALORE分布式数据库网络的跨区域真实世界研究

2025-11-050
PRE
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large-Scale Multi-Regional Italian Study Through the VALORE Distributed Database

炎症性肠病患者对生物制剂的依从性轨迹:一项基于VALORE分布式数据库的大型多区域意大利研究

2025-10-010
OAAI
Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network

单次和多次转换、交换及重新转换在28,073例炎症性肠病生物制剂使用者中的研究:意大利VALORE网络的结果

2025-09-280
OA
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network

老年免疫介导性炎症疾病患者生物制剂使用频率:来自意大利VALORE分布式数据库网络的大规模研究结果

2025-04-030
OA
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
2024-12-210
OA
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021
2024-06-110
OAAI
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
2024-05-214
PRE
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

7月19日2021年12月12日,在意大利delta变体的主要循环期间,mRNA疫苗加强剂量对 ≥ 60岁和其他高危人群的SARS-CoV-2感染和严重新型冠状病毒肺炎的有效性

2022-04-156
OA
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study

意大利delta变体主要循环期间mRNA疫苗的有效性以及对SARS-CoV-2感染和严重新型冠状病毒肺炎的保护作用减弱: 回顾性队列研究

2022-02-1067
OAAI
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial
2021-11-2951
OAAI
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
2021-10-1222
OAAI
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-COV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study
2021-07-0112
OAAI
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021
2021-06-2425
OAAI
Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network

意大利北部新型冠状病毒肺炎住院患者的生存率: ITA-COVID-19网络基于人群的队列研究

2020-12-0144
OAAI